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Serotype 1 Streptococcus pneumoniae is a leading cause of invasive pneumococcal disease (IPD) worldwide, with the
highest burden in developing countries. We report the whole-genome sequencing analysis of 448 serotype 1 isolates from
27 countries worldwide (including 11 in Africa). The global serotype 1 population shows a strong phylogeographic structure
at the continental level, and within Africa there is further region-specific structure. Our results demonstrate that region-
specific diversification within Africa has been driven by limited cross-region transfer events, genetic recombination and anti-
microbial selective pressure. Clonal replacement of the dominant serotype 1 clones circulating within regions is uncommon;
however, here we report on the accessory gene content that has contributed to a rare clonal replacement event of ST3081
with ST618 as the dominant cause of IPD in the Gambia.
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Data Summary
1. Supplementary Tables S3 & S5 have been deposited in
FigShare: DOI – 10.6084/m9.figshare.1472901 (URL –
http://dx.doi.org/10.6084/m9.figshare.1472901).
2. Study genomes have been deposited in GenBank; acces-
sion numbers are detailed in Supplementary Table S6
which has been deposited in FigShare: DOI – 10.6084/
m9.figshare.1472901 (URL – http://dx.doi.org/10.6084/
m9.figshare.1472901).
Introduction
Streptococcus pneumoniae is a commensal bacterium
commonly isolated from the human nasopharynx (Turner
et al., 2012). It is a major cause of morbidity and mortality
worldwide, manifesting as a range of clinical infections,
from sinusitis and acute otitis media tomeningitis, septicae-
mia and pneumonia, with the highest disease burden in
developing countries (O’Brien et al., 2009). S. pneumoniae
is conventionally subdivided into more than 90 different
serotypes (Bentley et al., 2006), which have differing disease
associations (Hausdorff et al., 2005; Yildirim et al., 2010).
For a century, serotype 1 has ranked among the most preva-
lent pneumococcal serotypes causing invasive pneumococ-
cal disease (IPD) worldwide (Harboe et al., 2010).
In Africa, serotype 1 is the second most common cause of
IPD (proportion of IPD: 11.7 %) after serotype 14 (Johnson
et al., 2010).
Serotype 1 has distinct characteristics compared with other
pneumococcal serotypes; it shows even distribution of inci-
dence across all age ranges, is linked to outbreaks in closed
communities and is associated with epidemic outbreaks in
West Africa (Antonio et al., 2008; Dagan et al., 2000; Ritchie
et al., 2012). Furthermore, serotype 1 is rarely associated
with antimicrobial resistance (Brueggemann et al., 2003;
Hausdorff et al., 2005). Short duration and low densities of
serotype 1 during colonization may explain low resistance
levels because recombination with other streptococci in
the nasopharynx is a major source of resistance in pneumo-
cocci (Brueggemann & Spratt, 2003; Williams et al., 2012).
The high burden of disease caused by serotype 1 was the
impetus for clinical trials of the nine-valent conjugate
vaccine (PCV9) in the Gambia and South Africa, the first
conjugate vaccine to incorporate serotype 1 capsular poly-
saccharide (CPS) (Cutts et al., 2005; Klugman et al., 2003).
PCV10 and PCV13 are currently being rolled out across
Africa. Both incorporate serotype 1 CPS (Klugman et al.,
2008); however, comprehensive impact evaluation data for
these vaccines are not yet available (Blumental et al., 2015).
Genetic characterization of a global collection of 166 sero-
type 1 pneumococci using MLST identified three lineages
each associatedwith different regions of the world, with line-
age B associated with Africa (Brueggemann & Spratt, 2003).
Within regions there was further suggestion of phylo-
geographic structure but the sample size and low resolution
of MLST limited the conclusions that could be made.
In recent years, whole genome sequencing has emerged as
a practical method for studying bacterial genetics across
large numbers of samples, allowing reconstruction of high-
resolution phylogenies and correlation of complete gene
catalogues with phenotypic and clinical data (Croucher
et al., 2011; Harris et al., 2010; Ko¨ser et al., 2012).
Impact Statement
Streptococcus pneumonia serotype 1 is a leading cause
of pneumococcal pneumonia and meningitis globally,
with the highest burden of disease in the developing
world. In this study we sequenced a global collection
of S. pneumoniae serotype 1 isolates and show that ser-
otype 1 in Africa is genetically distinct from serotype 1
in the developed world. Within Africa, serotype 1 has
disseminated and diversified between countries in
response to region-specific selective pressures. Recom-
bination and antibiotic usage have contributed to this
diversification. Of interest, serotype 1 is subject to the
same level of recombination as other serotypes com-
monly associated with nasopharyngeal carriage. This
contradicts the view that short duration of carriage
limits the opportunity for serotype 1 to recombine
and acquire antibiotic resistance mechanisms.
We demonstrate that long-range transmission of sero-
type 1 is rare, with locally circulating clones in
countries remaining stable with little impact from
imported clones. In a rare example of clone replace-
ment, the serotype 1 clone ST3081 replaced ST618 as
the dominant cause of invasive pneumococcal disease
in the Gambia in 2006.We report on the virulence fac-
tors unique to ST3081, which have likely driven this
replacement. This is the largest reported sequencing
collection of a single S. pneumoniae serotype to date.
Our analysis shows how country-specific selective
pressures have driven the evolution and diversification
of this important pathogen within Africa.
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Herewe present awhole genomephylogeny of 448 serotype 1
pneumococcal isolates, recovered from 27 countries world-
wide (including 11 in Africa) in order to investigate the
genetic diversity of this important pathogenic serotype and
relate this to clinical phenotype. We also investigate the
evolutionary mechanisms and specific selective pressures
that have driven the diversification of serotype 1 within
Africa.
Methods
Whole genome sequencing. S. pneumoniae was cultured
and genomic DNA extractions were performed as described
elsewhere (Everett et al., 2011). Multiplex DNA sequencing
using the Illumina Genome Analyser GAII (Illumina) was
performed, as previously described (Harris et al., 2010).
The sequence reads generated were deposited in the
European Nucleotide Archive (ENA) (http://www.ebi.ac.
uk/ena/) under study number ERP000156, a full list
of accession numbers is available in Table S1 (available in
the online Supplementary Material). All isolates had
previously tested positive as serotype 1 pneumococci by
PCR using a standard protocol (Pai et al., 2005).
To confirm all of the study isolates were serotype 1 we also
employed an additional in silico serotyping method,
whereby the sequence reads were redundantly aligned
against the concatenated sequences of 94 pneumococcal
CPS loci using BWA (Li & Durbin, 2009). The CPS locus
with the highest proportion of its length covered by
mapped reads was taken as the serotype (Croucher et al.,
2011). We observed 100 % concordance between the PCR
and in silico serotyping results; all of the study isolates
exhibited the highest mapping to the serotype 1 CPS locus.
The seven MLST loci were extracted from the assembled
sequence reads and compared with the MLST.net
pneumococcal database using the short read sequence
typing (SRST) tool (Inouye et al., 2012).
Phylogeny reconstruction. Sequence reads were mapped
against serotype 1 S. pneumoniae P1041 (accession number:
FQ312030) using SMALT (http://www.sanger.ac.uk/resources/
software/smalt), giving, on average, 185| depth of coverage
for more than 94.4 % of the reference genome (Fig S1). SNPs
were identified as described by Harris et al. (2010).
A phylogenetic tree was reconstructed for all SNP sites in
the genomes using RAxML v.7.0.4 (Stamatakis, 2006).
A General Time-Reversible (GTR) model with gamma
correction for among-site variation was used with 10
starting trees. To assess support for nodes, 100 random
bootstrap replicates were performed. Recombinant sites in
the lineage B isolates were identified as previously described
and the phylogeny was reconstructed for all SNP sites
independent of recombinant blocks (Croucher et al., 2011).
Nucleotide substitution rate. Rates of single nucleotide
substitution for the five lineage B clades, which featured
African isolates (clades i, ii, iii, v and vi) were calculated
with Bayesian Evolutionary Analysis by Sampling Trees
(BEAST), using 2 000 000 Markov Chain Monte Carlo
(MCMC) iterations sampled every 1000 steps
(Drummond et al., 2012). The nucleotide substitution
rate between clades was compared using the Kruskal–
Wallis test. Rates of recombination for each clade were
calculated as previously described (Croucher et al., 2011)
and compared using the Kruskal–Wallis Test.
Genome assembly and annotation. Genomes for the
lineage B isolates were de novo assembled using a pipeline,
which iteratively ran Velvet (Zerbino & Birney, 2008)
(with k-mer size ranging between 60 and 90 % of the read
length), SMALT and SSPACE (Boetzer et al., 2011). This
pipeline gave on average a total length of 2 063 265 bp,
with average contig length of 19 660 bp and average N50
of 9733 bp. Assembly statistics are summarized in
supplementary Table S1. De novo gene prediction was
performed using Glimmer (Delcher et al., 1999) and
annotation was transferred using PROKKA (Seemann, 2014).
Antimicrobial resistance analysis. Individual gene trees
for folA and folP were reconstructed with RAxML v.7.0.4
(Stamatakis, 2006) using a GTR model with GAMMA
correction using 100 bootstraps. Display and
manipulation of the single gene phylogenetic trees was
performed using the online interactive tree of life
(Letunic & Bork, 2011). On the basis of the prediction of
recombination in isolates from the four main study sites
(Malawi, The Gambia, South Africa and Niger) for which
complete antimicrobial resistance data were available,
isolates undergoing folA and folP recombination and
their phenotypic resistance to co-trimoxazole were
compared with strains with no recombination events
detected at these sites. A Kruskall–Wallis test was used to
estimate the statistical difference between the two groups.
Core genome analysis (lineage B). Annotated genes
were translated to protein sequences and assigned to
orthologous gene ‘clusters’ using OrthoMCL, with BLASTP
E-value cut-off 1e25 and inflation index 1.5 (Li et al.,
2003). A stringent quality control process was applied to
the genome assemblies, to ensure that poor assembly of
small genomic regions did not result in an underestimate
of the core genome size (Table S1). The resulting
orthologous clusters were organized into a matrix of
genome content using bespoke Perl scripts, with
orthologues from the same genome arranged in columns
and rows identifying annotated orthologues of similar
function. A blank (‘-’) was inserted where an orthologue
was absent. Genomes (the matrix columns) were
randomly sampled in an arithmetic progression fashion:
SN5N/2[2a+(N21)d ]. The number of random sampling
events, SN, was established using the least number of
genome(s) under consideration, a (i.e. 1 genome in this
study), the total number of genomes under consideration
(i.e. the dataset size), N, and the common difference of
successive genomes, d, (i.e. 1) to be used during sampling.
During random sampling, the total number of genomes,
Region-specific diversification of serotype 1 S. pneumoniae
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N, was initialized as one genome for the first event, and
increased by one unit for each of the subsequent events,
until it was equivalent to the total number of genomes in
the dataset in the final event. The random genomes were
only sampled once during each event and the total number
of orthologues shared by all genomes was counted once for
each cluster, thereby excluding paralogous counts. This
was iterated 100 times resulting in 100 input orders for
each event; the arithmetic mean core genome size was
computed for each event to enable the mean core genome
size to be related to the number of genomes sampled (Fig.
S2). Comparisons of core genomes from different datasets
were achieved using Perl scripts (https://github.com/fy2/
pneumoscript).
0.00065
[B]
[C]
[D]
[A] Continents
Africa
South America
Europe
Asia
Oceania
Fig. 1. Phylogeography of serotype 1 S. pneumoniae isolates. Maximum-likelihood phylogenetic tree based on the whole genome SNPs
of serotype 1 isolates annotated with country of origin. The colour of each isolate indicates the continent of origin: red, Africa; orange,
Asia; green, Europe; blue, South America (the Brazilian group is highlighted by a circle, the Argentinian and Peruvian isolates are high-
lighted by a star); purple, Oceania. Specific lineages referred to in the text are labelled: A (lineage A, Europe, South America & Oceania),
B (lineage B, Africa), C, (lineage C, South America), D (lineage D, Asia). Note that Asian isolates are present in all of the lineages.
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Results
Global population structure of serotype 1
Whole genome sequencing was performed for 448 serotype
1 isolates collected from 27 countries between 1994 and
2009 (see supplementary material for sampling strategy,
Fig. S3, Table S2, Table S3). Short reads for each
isolate were mapped against the genome of serotype 1
S. pneumoniae P1041 and SNPs were identified.
A maximum-likelihood phylogeny based on 58 718 SNPs
is presented in Fig. 1. The study isolates grouped into
four lineages (A–D). Lineages A to C have been previously
reported based on MLST (Brueggemann & Spratt, 2003);
here we report a previously unrecognized clade (lineage
D), composed of Asian isolates. We observed a striking
continental clustering, indicating significant geographical
structure in the global population. The African isolates
all grouped within a single lineage (lineage B). The Euro-
pean isolates all fell within lineage A. All isolates from
Oceania fell within a distinct lineage A subclade.
In contrast, isolates from Asia were found in all four
lineages, suggesting multiple intercontinental transfer
events. The South American isolates grouped into two
lineages; isolates from Peru and Argentina formed distinct
lineage C subclades and isolates from Brazil grouped
within lineage A. Despite the inclusion of a low number
of isolates from outside of Africa, four continents (Asia,
Europe, South America and Oceania) were represented in
lineage A, suggesting this lineage is subject to a relatively
greater frequency of intercontinental transfer events.
Phylogeography of serotype 1 within Africa
The lineage B phylogeny was reconstructed with variation
due to recombination removed (Croucher et al., 2015)
(Fig. 2). The phylogeny consisted of six major clades
(labelled i–vi) and showed a high level of geographical
structure. The Malawi isolates formed a single clade
along with isolates from Mozambique (clade vi), indicating
serotype 1 pneumococci remained genetically stable in
Malawi over the sampling period with no detectable
impact from imported clones. The South Africa isolates
(with two exceptions) formed a single clade, ii. Malawi
and South Africa are in relatively close geographical proxi-
mity, yet clades vi and ii are phylogenetically distant,
suggesting genotypic stability of serotype 1 in these
countries and limited inter-country transfer. A South Afri-
can isolate grouped within clade iv; subsequent research
revealed this isolate was recovered from a Mozambican
in South Africa. The Mozambique isolates fell in two
clades, 30/51 (59 %) clustered with the Malawi isolates
(clade vi) and 21 (41 %) clustered with the South Africa
isolates (clade ii). This indicates multiple inter-country
transfers between Mozambique and bordering countries,
Malawi and South Africa. Civil war in Mozambique saw
a mass influx of 1.7 million refugees into bordering
countries, the post-war return of refugees to Mozambique
may have led to the importation of serotype 1 clones which
became dominant within Mozambique (United Nations
High Commissioner for Refugees, 2000).
The North African isolates showed clear separation from
the southern African isolates (Fig. S4). The majority
(61 %, 88/145) lay within the second most diverse clade,
iii (based on average terminal branch lengths; Fig. S5),
which also contained isolates from Asia. Despite the high
number of countries represented in clade iii there was a
relatively high level of country-specific clustering, implying
that inter-country transfer events were infrequent. How-
ever, a single South African isolate grouped within clade
iii, inferring a cross-region transfer event.
The Gambia isolates were an anomaly, only a subset (6 %,
3/50) grouped within clade iii with the other West African
isolates. The majority clustered in clades i and v. The
Gambia isolates in clade i (14 %, 7/50) and v (72 %, 36/
50) belonged to ST618 and ST3081, respectively
(Fig. S6). In the Gambia, ST618 previously dominated,
causing w70 % of serotype 1 IPD from 1995 to 2006
(Antonio et al., 2008). ST3081, first detected in the
Gambia in 2006, has replaced ST618 as the dominant
cause of IPD. ST3081 has only been previously reported
in Oman in 2004 (MLST.net). Consistent with the expan-
sion of a newly emergent clone, clade v was the least diverse
within the phylogeny (Fig. S5). A further three Gambia iso-
lates (6 %) grouped within clade vi, separated from the
Malawian and Mozambique subclade by a long branch
length, suggesting a historical cross-region transfer event.
Clade v consisted solely of isolates from Asia and was
excluded from subsequent analyses.
Recombination and resistance
We next investigated the evolutionary mechanisms that
contributed to the diversification of serotype 1, lineage B
in Africa. Consistent with the substitution rate reported
elsewhere, (Croucher et al., 2011, 2013) the mean esti-
mated substitution rates of the lineage B African clades
ranged from 1.714|1026 to 5.980|1026 per site per
year (P54.6|1029). Of 38 187 SNPs identified, 30 597
(79.9 %) were introduced by 650 recombination events,
ranging in size from 3 bp to 82 054 bp (Fig. S7).
We found a significant difference in the rec/m (ratio of
homologous recombination events to point mutations)
between clades (P53.2|1024), which ranged from 0.03
in clade ii to 0.14 in clade i (Fig. 3). This is the first dem-
onstration of varying recombination rates within a single
pneumococcal lineage.
The majority of recombination events detected were on
branches between clades (ancestral recombination) (426/
650, 66 %) (Fig. 2). Analysis of recombination events on
branches within clades (recent recombination) showed a
number of genes recombined multiple times in some
clades, but did not undergo recombination in others.
These recombination events may have been driven by
Region-specific diversification of serotype 1 S. pneumoniae
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clade-specific selective pressures (Table S4) (Fig. 4). Unique
to clade iii isolates from the Gambia, Ghana, Niger and Togo
(and a subset of Asian isolates), were recombination events
involving pbp1a, pbp1b and pbp2a, allelic variants of which
confer beta-lactam resistance (Cornick & Bentley, 2012).
Likewise, gyrA and parC, allelic variants of which confer
fluoroquinolone resistance, were only subject to recombina-
tion in Malawi isolates (clade vi). Insufficient antimicrobial
resistance data were available to correlate recombination to
resistance; however, it is probable that recombination in
these areas reflects high antimicrobial consumption.
The gene subject to the highest number of unique recom-
bination events in clades i and iii was folP (dihydropteroate
0M
bp
2M
bp
0.098
Asia
Bangladesh
The Philippines
Nepal
India
Thailand
Qatar
North-west Africa
The Gambia
Nigeria
Niger
Ghana
Togo
Senegal
North-east Africa
Egypt
Ethiopia
Southern Africa
Malawi
South Africa
Mozambique
[i]
[ii]
[iii]
[iv]
[v]
[vi]
Fig. 2. Reconstructed maximum-likelihood phylogeny of serotype 1, lineage B isolates. The phylogeny is solely reconstructed using SNPs
outside of recombinant blocks. The scale bar represents substitutions per SNP. The colour of each isolate indicates the country of origin.
The panel next to the phylogeny shows the genomic locations of putative recombination events detected in each terminal taxon. Red
blocks indicate recombination events that have occurred in multiple isolates. Blue blocks indicate recombination events that have occurred
in a single isolate. The background colour of the panel indicates the region of origin.
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synthase); folA (dihydrofolate reductase) was also subject
to multiple recombination events in clades iii and iv. Allelic
variants of these two genes confer resistance to co-trimox-
azole and sulfadoxine/pyrimethamine (SP) (Cornick et al.,
2014) (Fig. 5, Table S5). We investigated if there was an
association between recent recombination and antimicro-
bial resistance for the 210 isolates from the four main
study sites where resistance data were available; (the
Gambia n543, Malawi n564, Niger n531, South Africa
n558). The isolates that underwent recent folA recombina-
tion (10 %, 25/210) were phenotypically more resistant
than those that had not (average MIC 4.0 vs 2.1 mg
ml21, P51.9|1024), in contrast to a previous report
(Chewapreecha et al., 2014). However, isolates that had
undergone a recombination at folP (33 %, 40/210) were
phenotypically less resistant than those that had not
(average MIC 0.7 vs 2.6 mg ml21, P59.5|10215).
Recent recombination events in folA were unique to a
subset of the Malawian isolates and a single isolate from
Niger. All of the Malawi isolates were co-trimoxazole
resistant; recent recombination had introduced the resist-
ant folA genotype (Ile-100-Leu of DHFR). All of the
Malawi isolates also possessed the folP resistance genotype
(a 1–2 aa insertion in DHPS). The folP phylogeny (Fig. 5)
showed that the folP sequences clustered based on country
of isolation, suggesting that the folP resistance genotype
was introduced through a historical recombination event
or spontaneous mutation and disseminated within the
population. SP was extensively used as a first-line treat-
ment for uncomplicated malaria in Malawi from 1993 to
2007. In 2005, co-trimoxazole preventative therapy
(CPT) for individuals with HIV became national policy.
This represents a potentially strong selective pressure for
pneumococci to acquire and maintain co-trimoxazole
resistance. Recent recombination events at folP were
unique to a subset of South African isolates and four Gam-
bian isolates. Despite extensive CPT use and evidence of
recent folP recombination in the South African isolates,
no resistance was observed in these isolates. South Africa,
however, has a low incidence of malaria and therefore
low SP consumption. The recent recombination events in
folP in the South African isolates may be a result of the
introduction of CPT placing a ‘new’ selective pressure
and in time a recombination event may introduce the
resistance genotype.
Resistance due to mobile genetic elements
Amongst the subset of 210 isolates we found that 49 %
(102) were tetracycline-resistant and 31 % (65) were chlor-
amphenicol-resistant (Table S5). The presence of tetM and
cat, which confer tetracycline and chloramphenicol resist-
ance, respectively, was assessed. TetM was identified in
53 % (112) and cat in 33 % (70) of isolates (Fig. 6). Two
allelic variants of TetM dominated in the dataset, one
associated with north-west Africa and the other southern
Africa, both alleles were associated with a MIC of w8 mg
ml21. All but one of the Malawi (clade vi) isolates har-
boured TetM; conversely none of the South Africa (clade
ii) isolates encoded TetM. TetM was identified in all
three of the north-west African clades, including 84 %,
(26/31) of the Niger isolates and four Gambia isolates
(9 %, 4/43). Allelic variants of Cat were also associated
with different African regions. CatO was only identified
in southern Africa; consistent with high phenotypic resist-
ance, all of the Malawi isolates encoded CatO. The CatQ
protein was unique to north-west Africa; however, it was
only identified in three Gambia isolates (clade i), none of
which displayed phenotypic resistance, and a single resist-
ant Niger isolate. Tetracycline and chloramphenicol are
readily available across Africa and it is unclear why these
resistance mechanisms are only present in specific
countries. The findings contrast with other studies, that
report low levels of antimicrobial resistance in serotype 1
(Williams et al., 2012).
Region- and lineage-specific gene content may
explain differences in disease phenotype
We defined the core and accessory serotype 1 genome for
the six African lineage B clades. We identified 2305 ortho-
logous gene clusters in the dataset. Fifty-nine per cent
(59 %) (1358 core genes) were present in all of the study
isolates. The remaining 842 (37 %) genes were present in
two or more isolates (accessory genes), whilst 105 genes
(5 %) were unique to a single isolate.
We identified 53 accessory genes that were absent in at least
one clade but present in 100 % of isolates in at least one
clade (Fig. 7, Table S6). Unique to the predominantly
North African clades (i and iii) was a bacteriocin 972
family protein. This protein has been shown to contribute
to the infectivity of Streptococcus iniae (Li et al., 2014).
A peptidylprolyl isomerase (PpiA) protein was present in
0
0.02
0.04
0.06
0.08
0.1
0.12
0.14
0.16
Clade i Clade ii Clade iii Clade v Clade vi
re
c/
m
Fig. 3. Recombination dynamics of serotype 1 pneumococci.
The mean rec/m (number of homologous recombination events/
number of SNPs introduced through spontaneous mutation) for
the lineage B African clades. Error bars represent the 95 % con-
fidence interval.
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the Malawi and Mozambique isolates in clade vi and a
subset of North African isolates (clade iii). A homologue
of PpiA reduces phagocytosis in Streptococcus mutans
(Iyer et al., 2001). Three genes from a phosphotransferase
system (PTS) were present in all of the isolates in the North
African clades (i and ii). PTS plays a key role in pneumo-
coccal colonization (Mukouhara et al., 2011). The distri-
bution of these accessory genes may reflect host-specific
selective pressures between regions and explain differences
in disease severity between these regions.
As discussed earlier, the lineage B phylogeny (Fig. 2) indi-
cates that there were two distinct, genetically unrelated
groups of isolates from the Gambia, ST618 and ST3081.
In 2006, ST3081 replaced ST618 as the dominant cause
of IPD in the Gambia. MLST does not have the resolution
to distinguish the genes exclusive to ST3081, which have
driven sequence type (ST) replacement. To look at large
accessory elements, rather than absence/presence of indi-
vidual genes, we took a semi-manual approach to the cre-
ation of the Gambia accessory genome (see Methods)
(Fig. 8). Accessory regions present in all ST3081 isolates
but absent in ST618 isolates included a 6.2 kb phage
element, encoding an integrase site-specific recombinase
(XerD), a cell division protein, FtsK/SpoIIIE, and a
fucose utilization operon first characterized in serotype 3
(SP3-BS71) (Higgins et al., 2009). Unique to all of the
ST618 isolates was a type 2 fucose utilization operon,
first characterized in S. pneumoniae TIGR4 (Chan et al.,
2003) (Fig. S8). Fucose utilization operons have been
shown to be essential to pneumococcal virulence in
models of pneumonia and otitis media (Embry et al.,
2007). It is possible that the SP3-BS71-type operon
found in ST3081 allows ST3081 to outcompete ST618 iso-
lates, which possess the type 2 operon. Of the remaining
proteins unique to ST3081, XerD has previously been
implicated in pneumococcal virulence (Chalker et al.,
2000). FtsK has not previously been implicated in pneumo-
coccal virulence; however, it interacts with Xer proteins (Le
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Fig. 5. Association between clade-specific recombination events involving folA and folP and co-trimoxazole resistance. (a) The centre
phylogeny is based on the SNP differences between folA from 210 lineage B isolates. (b) The centre phylogeny is based on the SNP
differences between folP from the same dataset. The inner circles represent the lineage B clades from which the genes were isolated.
The middle circles are coloured according to the co-trimoxazole resistance phenotype. The outer ring indicates if folA or folP was involved
in a clade-specific recombination event. The scale bar represents substitutions per SNP.
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Fig. 6. Distribution of the antimicrobial resistance proteins Tet and Cat in serotype 1 pneumococci. The centre phylogeny is based on the
whole genome SNP differences between 210 lineage B isolates, the inner rings are annotated with the country of origin and coloured
according to the lineage B clade which the isolate belongs to. (a) The middle ring is coloured according to the tetracycline resistance
phenotype, the outer ring according to the absence/presence of Tet. (b) The middle ring is coloured according to the chloramphenicol
resistance phenotype, the outer ring according to the absence/presence of Cat. The scale bar represents substitutions per SNP.
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Bourgeois et al., 2007), suggesting that FtsK may play an
indirect role in the regulation of pneumococcal virulence.
Discussion
The global serotype 1 population shows a strong phylo-
geographic structure at a continental level with further
country-specific phylogeographic structure evident within
Africa. The data suggest that serotype 1 has disseminated
within Africa and diversified independently within the
continent, likely due to country- and population-specific
selective pressures. There is limited evidence of inter-
country transfer events within the African continent,
arguably due to the dominance of locally circulating
clones, limiting the scope of new clones to become
established within the population, and the short carriage
Fig. 7. Reconstructed maximum-likelihood phylogeny of serotype 1, lineage B isolates. The phylogeny is solely reconstructed using SNPs
outside of recombinant blocks. The scale bar represents substitutions per SNP. The colour of each isolate indicates the country of origin.
The panel next to the phylogeny shows the absence/presence of accessory genes in each isolate. Red blocks indicate an accessory gene
is present (blue blocks indicate an antimicrobial resistant accessory gene is present). Putative or hypothetical accessory genes are not
included in this figure.
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Fig. 8. Phylogeny of ST618 and ST3081 serotype 1 S. pneumoniae isolates recovered from the Gambia. Maximum-likelihood phyloge-
netic tree based on the whole genome SNPs of serotype 1 isolates annotated with ST. The scale bar represents substitutions per SNP.
The colour of each isolate indicates its ST: blue, ST3081; red, ST217; purple, novel ST; orange, ST303; green, ST618; turquoise,
ST2084. The panel next to the phylogeny shows the presence (red) or absence (blue) of accessory genes for each of the study isolates.
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duration of serotype 1 limiting opportunity for inter-
country transfer. Yet, the relatively high rec/m reported
here suggests that this serotype is carried for periods long
enough to allow extensive recombination. We report
levels of recombination in serotype 1 in line with other ser-
otypes that are commonly associated with carriage and
antimicrobial resistance (Chewapreecha et al., 2014; Crou-
cher et al., 2011). Our data suggest that recombination and
antimicrobial consumption have contributed to the diver-
sification of serotype 1 in Africa. We observed recombina-
tion events in the targets of co-trimoxazole or SP and to a
lesser extent fluoroquinolone and beta-lactam antimicro-
bials. The varying rates of recombination and frequency
of recombination encompassing these genes between line-
age B African clades show evidence of adaptation to differ-
ent environmental pressures within geographically isolated
clades. The distribution of transposable resistance elements
in the accessory genome conferring tetracycline and chlor-
amphenicol resistance further supports that antimicrobial
usage has shaped diversification. The accessory genome
of serotype 1 is highly variable between regions; region/
clade-specific genes are implicated in virulence and evasion
of the host immune response, suggesting that difference in
host genetics between regions is also driving diversifica-
tion. Furthermore, the phylogeny shows that long-range
transmission of serotype 1 is rare. This lack of long-range
transmission has led to the divergence of geographically
isolated clades, which have remained stable with little
impact from imported clones. In summary, our data
show that serotype 1 is genetically distinct in Africa relative
to other continents and furthermore is distinct between
regions of Africa. Clonal replacement of the dominant ser-
otype 1 clones circulating within regions is rare; however,
we report the accessory gene content that has likely
driven decisive serotype clonal replacement in the Gambia.
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